As $GILD Remdesivir gains FDA Approval - it’s Combined NIAID BET trial with HGEN Lenzilumab begins recruiting - with the current COVID wave - it should fill quickly.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.